drugset / Trial / NCT01249651
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
NaSingle-groupOpen-labelTreatment
Summary
Administration of esomeprazole 40 mg to subjects who still had heartburn after receiving rabeprazole 20 mg once daily for 4 to 8 weeks will result in statistically significant improvement of heartburn after 8-week treatment.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-06
- Completion
- 2011-06
Outcome
Met primary endpoint
registry MEAN Arm 1 - Esomeprazole 40 mg: -3.3 (Standard Deviation 2.36) Number of days NCT01249651 ↗
registry p <0.001; Wilocoxon signed-rank test NCT01249651 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 40 mg | — |